Peptidomics offered new diagnostic insights into the underlying processes of metabolic dyfunction-associated steatotic liver ...

Fatty liver disease happens when too much fat builds up in the liver. It’s one of the most common liver problems in the world, affecting millions of people. While it often doesn’t cause ...

Serum uric acid (SUA) levels independently predict nonalcoholic fatty liver disease (NAFLD, now known as metabolic dysfunction–associated steatotic liver disease) in young adults without obesity ...

Mission Statement: Evidence-based Complementary and Alternative Medicine (eCAM) is an international, peer-reviewed journal that seeks to understand the sources and to encourage rigorous research ...

Fatty liver disease, or hepatic steatosis, occurs when excess fat accumulates in liver cells. Commonly associated with obesity, type 2 diabetes, and excessive alcohol consumption, it can lead to ...

Alzheimer's predominantly impacts women due to factors like hormonal issues, genetic predispositions, and mental well-being.

Background Non-alcoholic fatty liver disease (NAFLD) describes the presence of hepatic steatosis in the absence of significant alcohol use affecting one-third of the global population. However, an ...

Metabolic dysfunction-associated steatotic liver disease (MASLD), previously known as non-alcoholic fatty liver disease, is the most common cause of chronic liver disease in children. MASLD ...

Having more refined mouse models of metabolic dysfunction-associated steatotic liver disease (MASLD; also known as nonalcoholic fatty liver disease) will help to advance research into this disease.